Valuation Genomma Lab Internacional, S.A.B. de C.V.

Stocks

End-of-day quote Mexican S.E. 2026-08-14			5-day change	1st Jan Change
13.71 ^MXN	-0.80%		-4.53%	-23.37%

07-23	Genomma Lab Internacional, S.A.B. de C.V., Q2 2026 Earnings Call, Jul 23, 2026
07-23	Genomma Lab Internacional, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	21,614	16,849	13,161	23,244	17,474	13,368	-	-
Change	-	-22.05%	-21.89%	76.61%	-24.82%	-23.5%	-	-
Enterprise Value (EV) ¹	26,264	21,719	17,681	27,294	22,241	17,821	16,927	16,205
Change	-	-17.3%	-18.59%	54.37%	-18.51%	-19.88%	-5.02%	-4.26%
P/E	14.9x	12x	13.1x	11.7x	11.1x	5.36x	6.43x	5.65x
PBR	1.96x	1.75x	1.44x	2.26x	1.57x	0.95x	-	-
PEG	-	-5.76x	-0.6x	0.1x	-0.4x	0.1x	-0.4x	0.4x
Capitalization / Revenue	1.4x	1x	0.8x	1.25x	1x	0.71x	0.7x	0.66x
EV / Revenue	1.7x	1.29x	1.07x	1.47x	1.27x	0.95x	0.88x	0.8x
EV / EBITDA	8.18x	6.26x	5.12x	6.3x	5.42x	3.91x	3.81x	3.42x
EV / EBIT	8.57x	6.66x	5.48x	6.85x	5.92x	4.24x	4.18x	3.74x
EV / FCF	32.1x	13.4x	8.81x	9.77x	14.8x	16.1x	8.3x	6.99x
FCF Yield	3.11%	7.49%	11.4%	10.2%	6.77%	6.21%	12.1%	14.3%
Dividend per Share ²	0.3817	0.3817	0.1961	0.8	0.8	0.8342	1.232	1.585
Rate of return	1.78%	2.25%	1.38%	3.18%	4.47%	6.08%	8.98%	11.6%
EPS ²	1.44	1.41	1.08	2.14	1.61	2.56	2.132	2.425
Distribution rate	26.5%	27.1%	18.2%	37.4%	49.7%	32.6%	57.8%	65.4%
Net sales ¹	15,460	16,859	16,467	18,607	17,541	18,724	19,192	20,345
EBITDA ¹	3,210	3,471	3,454	4,330	4,101	4,558	4,448	4,745
EBIT ¹	3,063	3,263	3,224	3,982	3,760	4,198	4,052	4,328
Net income ¹	1,451	1,397	1,031	2,137	1,607	2,194	2,177	2,457
Net Debt ¹	4,650	4,870	4,520	4,050	4,768	4,453	3,559	2,837
Reference price ²	21.48	16.94	14.16	25.13	17.89	13.71	13.71	13.71
Nbr of stocks (in thousands)	1,006,240	994,639	929,461	924,946	976,728	975,033	-	-
Announcement Date	2/23/22	2/22/23	2/21/24	2/26/25	2/25/26	-	-	-

¹MXN in Million²MXN

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.	5.36x	0.95x	3.91x	6.08%	786M
ELI LILLY AND COMPANY	33.76x	12.18x	24.85x	0.59%	1,052B
JOHNSON & JOHNSON	28.96x	-	-	2.06%	627B
ABBVIE INC.	31.84x	7.42x	15.42x	2.75%	441B
ROCHE HOLDING AG	19.79x	4.7x	11.65x	2.81%	349B
NOVARTIS AG	21.42x	5.54x	13.77x	2.89%	287B
ASTRAZENECA PLC	19.89x	4.11x	11.68x	2.14%	241B
AMGEN INC.	26.26x	6.84x	12.14x	2.43%	224B
NOVO NORDISK A/S	13.32x	4.79x	9.96x	3.83%	202B
GILEAD SCIENCES, INC.	-42.28x	6.13x	23.96x	2.38%	172B
Average	15.83x	5.85x	14.15x	2.8%	359.6B
Weighted average by Cap.	24.17x	8.04x	17.73x	2%